Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-02-20

Grail's cancer test misses primary study goal in UK study

Endpoints News 2026-02-19

AbbVie, PhRMA can proceed with 340B case in Hawaii

Endpoints News 2026-02-19

When a health tech startup gets stuck in regulatory limbo

Endpoints News 2026-02-19

Teva beats Corcept in appeals fight over generic Cushing's syndrome drug

Endpoints News 2026-02-19

FDA formalizes one pivotal trial policy via NEJM perspective

Endpoints News 2026-02-19

Obesity biotech Verdiva plans big year of data, explores deals

Endpoints News 2026-02-19

Biogen stops part of an MS trial; Merck reports more Enflonsia data

Endpoints News 2026-02-19

Sanofi to expand in India; Stada invests $100M in Saudi Arabia

Endpoints News 2026-02-19

Hims to buy Australia’s Eucalyptus for $240M upfront in global push

Endpoints News 2026-02-19

Altesa raises $75M for oral respiratory med

Endpoints News 2026-02-19

J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug

Endpoints News 2026-02-19

J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug

Endpoints News 2026-02-18

Why clinical AI startup Kintsugi shut down

Endpoints News 2026-02-18

Senate health committee chair plots future FDA changes

Endpoints News 2026-02-18

Pharma is done negotiating as Trump pushes to codify deals

Endpoints News 2026-02-18

J&J pours $1B into new cell therapy site in Pennsylvania

Endpoints News 2026-02-18

Charles River highlights increase in demand as tariff uncertainties fade

Endpoints News 2026-02-18

Updated: Novartis signs macrocyclic deal with Unnatural Products

Endpoints News 2026-02-18

Novartis signs macrocyclic deal with Unnatural Products for $100M upfront

Endpoints News 2026-02-18

Reversal on Moderna's flu application follows atypical path through FDA

-507 / 33